Phosphoinositide-3 kinase antagonism does not reverse steroid insensitivity in severe asthma
A. Bhalla (Hamilton, Canada), K. Son (Hamilton, Canada), K. Radford (Hamilton, Canada), C. Huang (Hamilton, Canada), M. Kjarsgaard (Hamilton, Canada), M. Mukherjee (Hamilton, Canada), P. Nair (Hamilton, Canada)
Source: International Congress 2022 – In vivo and in vitro studies of airway diseases
Session: In vivo and in vitro studies of airway diseases
Session type: Thematic Poster
Number: 3173
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Bhalla (Hamilton, Canada), K. Son (Hamilton, Canada), K. Radford (Hamilton, Canada), C. Huang (Hamilton, Canada), M. Kjarsgaard (Hamilton, Canada), M. Mukherjee (Hamilton, Canada), P. Nair (Hamilton, Canada). Phosphoinositide-3 kinase antagonism does not reverse steroid insensitivity in severe asthma. 3173
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|